Objective To evaluate the performance and practicality of QuantiFERON TB-2G (QFT-2G) testing for screening healthcare workers (HCWs) at a city hospital in Japan without a tuberculosis (TB)-specific ward. Methods We performed a chart review of 951 HCWs (251 men and 700 women) who underwent QFT-2G testing as a part of their pre-employment or annual employee screening between April 2007 and March 2010. Results The initial QFT-2G test was interpreted as positive in 28 (2.9%) HCWs, negative in 884 HCWs (92.9%) and indeterminate in 39 HCWs (4.1%). During the four-year study period, 37 HCWs were diagnosed as being positive at least once. Nine (0.98%) of the 923 HCWs with indeterminate or negative results on the initial testing converted to a positive status, including 6/479 (1.25%) nurses, 2/100 (2.0%) office staff members and 1/147 (0.68%) physicians. No HCWs with a positive result had a history of tuberculosis (TB) or any apparent contact with active TB patients and did not opt for treatment of latent TB. Seven (25%) of the 28 HCWs who were determined to be positive on the initial testing reverted to an indeterminate or negative status. Conclusion In a series of annual serial QFT-2G tests, some HCWs exhibited conversion and/or reversion. Therefore, caution is required when interpreting mild fluctuations in interferon-γ responses.
Introduction
Healthcare workers (HCWs) are at increased risk of infection due to occupational exposure to tuberculosis (TB) patients. TB patients are incidentally referred to the hospital before a definitive diagnosis is confirmed, even if the hospital does not have a TB-specific ward. Yamauchi et al. reported that female nurses have a two-fold higher risk of developing active TB than the general population in Japan (1) . Therefore, preventing active TB is a fundamental challenge with respect to infection control in hospitals.
Two important components of TB infection control are routine screening for latent TB infection (LTBI) and the administration of chemoprophylaxis among HCWs. Based on the recommendation for the sequential performance of the two-step tuberculin skin test (TST) and the standard TST for newly hired HCWs (2), prior to 2006, we performed the TST in our hospital as an effective strategy for preventing nosocomial TB. However, the accuracy of the diagnosis of LTBI obtained with TST is sometimes doubtful due to the possibility of false-positive results in individuals who have received Bacillus Calmette-Guérin (BCG) vaccination and/or been exposed to non-tuberculosis mycobacterium infection (3). that the QuantiFERON-TB (QFT) test is more effective for identifying HCWs with LTBI in countries with a low prevalence of TB due to the elimination of the possibility of false-positive results caused by BCG vaccination (7) . Currently, most healthcare sector employees in North America undergo testing at the time of recruitment (8) . In Japan, there has been a steady increase in the number of medical facilities that request QFT test results as part of their preemployment examination. The main purpose of preemployment QFT testing is to identify the baseline immune status of each HCW, as LTBI can be screened if HCWs have been in contact with TB patients.
Since 2007, the QFT-2G test has been performed as a pre-employment and annual medical examination in our hospital. Few previous reports have examined serial QFT-2G tests over a four-year period. The present study aimed to evaluate the efficacy and practicality of QFT-2G testing for four years in HCWs at a second-level healthcare hospital without a TB-specific ward.
Materials and Methods

Participants
We examined all QFT records of HCWs at Iwata City Hospital (Shizuoka, Japan) between April 2007 and March 2010. This institution is a 500-bed second-level healthcare hospital without a TB-specific ward. In this hospital, the ratio of the number of cases of smear-positive TB/number of outpatients per year was 25 
QFT-2G testing
The QFT-2G tests were performed according to the manufacturer's recommendations (Cellestis, Carnegie, Australia). The test results were considered positive if the concentration of IFN-γ in the sample well following stimulation with the 6-kDa early secretory antigenic target of Mycobacterium tuberculosis (ESAT-6) and/or culture filtrate protein (CFP)-10 was " 0.35 IU/mL. The results were considered indeterminate if the IFN-γ level was " 0.10 IU/mL and <0.35 IU/mL in both antigen wells. The results were considered negative if the IFN-γ level was <0.10 IU/mL in both antigen wells.
We interpreted QFT conversion using the definition recommended by the US Centers for Disease Control and Prevention (CDC) (9), i.e., a baseline IFN-γ level of <0.35 IU/ mL and a follow-up IFN-γ level of " 0.35 IU/mL. QFT reversion was defined as a baseline IFN-γ level of " 0.35 IU/ mL with a follow-up IFN-γ level of <0.35 IU/mL.
QFT-2G testing was performed over a period of four years. We evaluated the performance and practicality of this modality for screening HCWs at our hospital.
Statistical analysis
All values were analyzed using the Dr. SPSS II for Windows software program (SPSS Inc., Chicago, USA). For the statistical analyses of the results of the initial QFT-2G testing and the characteristics of the positive, indeterminate and 
Results
Initial QFT-2G testing of the HCWs
Regarding the initial QFT-2G tests, 28 (2.9%) of 951 tests were interpreted as positive, 884 (92.9%) were interpreted as negative and 39 (4.1%) were interpreted as indeterminate. The median age of the HCWs with a positive result was 44 years (range, 22-64 years), which was significantly higher than that of the HCWs with a negative result (p<0.05, Table 3). The mean IFN-γ response level for ESAT-6 was 0.40±0.61 IU/mL, while that for CFP-10 was 1.03±1. 23 The median age of these subjects was 47 years (range, 24-66 years), including 19/492 (3.86%) nurses, 8/106 (7.55%) office staff members, 5/151 (3.31%) physicians, 3/ 89 (3.37%) medical technicians, 1/20 (5.00%) pharmacologists and 1/35 (2.85%) midwives. According to age, the rate of positive results increased from 2.2% among the subjects ! 29 years of age to 25% among those " 60 years of age (Fig. 1) .
A total of 923 HCWs had results that were interpreted as negative or indeterminate on the initial testing, nine (0.98%) of whom converted to positive results. All of these subjects were women, including 6/479 (1.25%) nurses, 2/100 (2.00%) office staff members and 1/147 (0.68%) physicians (Table 4 ). Five and six subjects converted with ESAT-6 and CFP-10, respectively, while two subjects converted with both ( Fig. 2A, B) . None of these subjects had a history of TB or exposure to active TB patients, and none opted for treatment of LTBI.
Seven of the 28 HCWs (25.0%) with a positive result on the initial testing reverted to an indeterminate or negative status over the four-year observation period. Four of these seven HCWs were women, and there were no significant differences in the rate of reversion between the generations (Table 5 ). This group consisted of 2/13 (15%) nurses, 3/6 (50%) office staff members, 1/3 (33%) medical technicians and one (100%) pharmacologist. Three and six subjects reverted with ESAT-6 and CFP-10, respectively, while two reverted with both (Fig. 2C, D) . 
Discussion
In this study, serial QFT-2G testing was performed at the pre-employment stage or during annual medical examinations between 2007 and 2010 among HCWs at a city hospital without a TB-specific ward. Each year, the rate of positive QFT-2G testing was approximately 3%. Although no HCWs with positive results had a medical history of TB or apparent contact with active TB patients, 0.98% of the HCWs with negative or indeterminate initial test results converted to positive results.
In Japan, 23,000 incident cases of TB were reported in 2010. Among them, 51% included elderly individuals >70 years of age, thus few incident cases of TB were reported among young people (10) . HCWs are known to be at risk for TB (11, 12) . Most HCWs are young and frequently have contact with elderly persons in routine practice. In order to prevent the spread of TB, infection control policies in many hospitals recommend the use of pre-and post-employment routine screening of HCWs using TST (3, 4) . However, the usefulness of TST is limited by its lack of specificity. In contrast, the IGRA test is more specific because it uses antigens not shared by any of the BCG vaccine strains or the more common species of non-tuberculosis mycobacterium (13) . The IGRA also has the advantage of exhibiting greater correlations with surrogate parameters of exposure to M. tuberculosis (14) (15) (16) and has a higher predictive value for LTBI progression to active TB (17, 18) .
However, some individuals show positive results on QFT testing without a medical history of TB or exposure to active TB patients. With regard to the rate of positive QFT testing, Hotta et al. reported a proportion of 1.4% among 207 healthcare students in a population deemed to be at a low risk for TB in Japan (19) . Among HCWs at a hospital with a TB-specific ward, Nakajima et al. showed a rate of positive QFT of approximately 10% (20) . We adopted the QFT-2G for routine screening of HCWs at our hospital in 2007, and the rate of positive testing has been approximately 3% each year. There may be a relationship between the rate of positive QFT and the frequency of contact with hospitalized active TB patients. In the present study, the positive group was older than the negative group, which is in agreement with the findings of previous reports showing that the rate of positive QFT is higher among elderly persons (21) (22) (23) . Furthermore, none of the HCWs in the positive group had a medical history of TB or exposure to active TB patients. QFT testing has been reported to have a high sensitivity and specificity for discriminating TB infection among low-risk groups (18); however, the positive predictive value in populations with a low prevalence of TB infection is significantly lower than that observed in populations with a high prevalence of TB. The QFT test may therefore not be effective when performed in populations with a low prevalence of TB infection due to the low positive predictive value.
In the present study, 0.98% (9/923) of the HCWs converted to positive results without developing TB, while 25% (7/28) reverted to negative results during the four-year observation period. With regard to occupation, there were no differences in the frequency of contact with TB patients between the groups, although we assumed that HCWs in close contact with TB patients exhibit a high conversion rate. Therefore, we may not have been able to detect the frequency of contact with patients as a risk factor for TB in our hospital because fewer TB patients visit our hospital compared with TB-specific hospitals.
In addition, among our HCWs who converted to positive results, the mean QFT-2G value was 0.35 IU/mL, which indicates a cut-off value between a positive and indeterminate status. There are currently no data regarding the degree of the increase in the IFN-γ response observed in patients with new TB infection as opposed to that due to test-related error or biological variation. Therefore, when interpreting test results according to current thresholds, the QFT is associated with a higher rate of conversion than the TST, with a 10-mm increment threshold, raising the possibility that the IGRA is more sensitive in detecting recent conversion (24, 25) . Pai et al. reported that it is uncertain whether a relatively small increase in the IFN-γ response constitutes a true conversion. Therefore, the optimal threshold for distinguishing new infection from nonspecific variation must be determined (8) . These authors also stated that it is important to consider the possibility that the sensitivity of IGRA for existing LTBI may be different from that for recent infection. The IGRA test may therefore facilitate the development of novel approaches to achieving nosocomial TB control. However, there is a potential risk of overtreatment, including the administration of LTBI therapy in uninfected HCWs, if nonspecific increases in IFN-γ are misinterpreted as being serious. Several definitions for QFT conversion, other than that recommended by the CDC, have been suggested, as follows: (1) (8) . However, which definition is the most appropriate is unclear. Well-controlled studies are required to further define the causes of individual variation in the IFN-γ response, and physicians should provide careful observation taking into consideration the risk of TB infection in individuals in whom the value of QFT increases remarkably. However, interpreting QFT test results alone may result in misdiagnosis, especially in facilities with less contact with TB patients, as observed in our hospital.
Performing QFT testing is relatively expensive. However, Fox et al. reported that QFT screening reduces direct costs by reducing the number of diagnosed cases of LTBI, thus reducing the cost of treatment (27) . In addition, in that study, QFT screening reduced the total number of clinic visits and the cohort exhibited increased adherence to TB prophylaxis compared with the TST cohort. The use of QFT results in superior clinical outcomes with lower costs than TST and should be considered in screening both non-BCG vaccinated and BCG-vaccinated new HCWs for LTBI (28) . However, Ito reported that the estimated cost of annual QFT tests to prevent TB among female general nurses in Japan is high and therefore did not recommend the annual use of QFT tests (29) .
Developing a uniform system of examination is difficult, as the frequency of contact with smear-positive patients differs among medical facilities. The frequency of QFT testing should be determined according to the frequency of contact with smear-positive patients. For example, high-risk groups should receive QFT testing every year, while low-risk groups should receive testing the at pre-employment examination or as needed. Annual QFT testing results in the easy diagnosis of LTBI because such testing demonstrates abnormal values different from conventional fluctuation in HCWs infected with TB. However, the need for annual QFT testing should be considered based on its cost-effectiveness. It is controversial whether QFT tests should be performed annually; therefore, the testing schedule must be determined at each medical facility.
Our study is associated with some limitations. First, QFT-2G results are affected by the time between sample collection and analysis as well as the method of preservation (30) . We performed QFT-2G testing in our hospital laboratory. However, technical errors were unlikely to have affected our QFT-2G test results because we tested >500 subjects every year. Second, none of the HCWs with positive QFT-2G results opted for treatment of LTBI, although we recommended such therapy. Therefore, we were unable to investigate the course of QFT-2G testing after treatment of LTBI.
QFT-2G testing may facilitate the development of novel approaches for achieving nosocomial TB control among HCWs; however, some concerns remain. In the present series of annual QFT-2G tests, several patients exhibited conversion and/or reversion. Therefore, caution is required when interpreting mild fluctuations in the IFN-γ response.
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